IFNA1 and immunoglobulin G4-related sclerosing disease: Therefore, we conclude that the serum concentrations of IFN-α and IL-33 may serve as biomarkers for the diagnosis of type 1 AIP/IgG4-RD, as well as for monitoring purposes.